The new British Thoracic Society (BTS) Guideline for Bronchiectasis in Adults has been published. This article provides a summary of key highlights of the new BTS Guideline and covers who to investigate, what investigations should be carried out and a management strategy.
Statistics from Altmetric.com
Contributors ATH led the development of the article. All authors were involved in the final editing and gave approval for the final document.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests All authors completed the annual Declaration of Interest form in line with BTS policy. ATH has declared funding from Bayer Healthcare, Boehringer Ingelheim. MRL has declared funding from Bayer Healthcare, Insmed, Pulmocide, Griffols, Polyphor, Savara.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.